强化与标准血压控制对认知域功能的影响:SPRINT子研究
SPRINT试验的预设计认知子研究纳入2921例50岁以上无糖尿病、卒中或痴呆的高血压患者,随机分入收缩压<120 mmHg强化组或<140 mmHg标准组。
要点
- 强化降压不显著改善记忆域,处理速度域下降略大但临床意义有限。
- 降压对认知的影响可能分散于多域,而非特定域。
- 本研究支持强化降压的认知安全性,但需结合主试验结果解读。
核心结论
- 强化收缩压控制与标准治疗相比,在记忆或处理速度域未产生临床相关差异。
- 降压对认知的影响可能并非集中于特定域,而是分散于多个认知域。
研究设计与样本
- SPRINT为开放标签、多中心随机对照试验,在美国和波多黎各102个站点开展。
- 参与者为50岁以上、收缩压>130 mmHg、无糖尿病、卒中史或痴呆的成人。
- 随机1:1分配至收缩压<120 mmHg强化组或<140 mmHg标准组。
- 认知子研究目标样本2800例,实际纳入2921例随机化参与者。
- 基线及每2年进行筛查和扩展认知测试,计划随访4年。
主要发现
- SPRINT因主要结局(心血管事件复合终点)获益而提前终止。
临床怎么用
- 强化降压至收缩压<120 mmHg未显示对记忆或处理速度的临床相关损害或获益。
- 临床决策应基于主试验的心血管获益,认知域特异性效果不显著。
局限性
- SPRINT因主要结局获益提前终止,随访时间可能不足以观察认知结局。
- 认知子研究为预设计亚组,样本和目标人群有限。
- 开放标签设计可能引入偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Results from the Systolic Blood Pressure Intervention Trial (SPRINT) showed that intensive control of systolic blood pressure significantly reduced the occurrence of mild cognitive impairment, but not probable dementia. We investigated the effects of intensive lowering of systolic blood pressure on specific cognitive functions in a preplanned substudy of participants from SPRINT. METHODS: SPRINT was an open-label, multicentre, randomised controlled trial undertaken at 102 sites, including academic medical centres, Veterans Affairs medical centres, hospitals, and independent clinics, in the USA and Puerto Rico. Participants were adults aged 50 years or older with systolic blood pressure higher than 130 mm Hg, but without diabetes, history of stroke, or dementia. Participants were randomly assigned (1:1) to a systolic blood pressure goal of less than 120 mm Hg (intensive treatment) versus less than 140 mm Hg (standard treatment). All major classes of antihypertensive agents were included. A subgroup of randomly assigned participants including, but not limited to, participants enrolled in an MRI substudy was then selected for a concurrent substudy of cognitive function (target 2800 participants). Each individual was assessed with a screening cognitive test battery and an extended cognitive test battery at baseline and biennially during the planned 4-year follow-up. The primary outcomes for this substudy were standardised composite scores for memory (Logical Memory I and II, Modified Rey-Osterrieth Complex Figure [immediate recall], and Hopkins Verbal Learning Test-Revised [delayed recall]) and processing speed (Trail Making Test and Digit Symbol Coding). SPRINT was registered with ClinicalTrials.gov, NCT01206062. FINDINGS: From Nov 23, 2010, to Dec 28, 2012, 2921 participants (mean age 68·4 years [SD 8·6], 1080 [37%] women) who had been randomly assigned in SPRINT were enrolled in the substudy (1448 received intensive treatment and 1473 received standard treatment). SPRINT was terminated early due to benefit observed in the primary outcome (composite of cardiovascular events). After a median follow-up of 4·1 years (IQR 3·7-5·8), there was no between-group difference in memory, with an annual decline in mean standardised domain score of -0·005 (95% CI -0·010 to 0·001) in the intensive treatment group and -0·001 (-0·006 to 0·005) in the standard treatment group (between-group difference -0·004, 95% CI -0·012 to 0·004; p=0·33). Mean standardised processing speed domain scores declined more in the intensive treatment group (between-group difference -0·010, 95% CI -0·017 to -0·002; p=0·02), with an annual decline of -0·025 (-0·030 to -0·019) for the intensive treatment group and -0·015 (-0·021 to 0·009) for the standard treatment group. INTERPRETATION: Intensive treatment to lower systolic blood pressure did not result in a clinically relevant difference compared with standard treatment in memory or processing speed in a subgroup of participants from SPRINT. The effect of blood pressure lowering might not be evident in specific domains of cognitive function, but instead distributed across multiple domains. FUNDING: National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute on Aging, National Institute of Neurological Disorders and Stroke, and the Alzheimer's Association.
引用
- Rapp SR, Gaussoin SA, Sachs BC, et al. Effects of intensive versus standard blood pressure control on domain-specific cognitive function: a substudy of the SPRINT randomised controlled trial. Lancet Neurol. 2020. PMID: 33098800. doi:10.1016/S1474-4422(20)30319-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。